Azstarys Capsule
Product Images NDC 65038-561

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Azstarys (NDC 65038-561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Commave Sub, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure-1 (Azstarys 01)

Chemical structure of Serdexmethylphenidate, one of the active ingredients in AZSTARYS capsules. The diagram shows molecular groups and connectivity including a phenyl ring, a piperidine ring, and ester and amide functional groups.*

FDA Label Image

Chemical Structure-2 (Azstarys 02)

Chemical structure of Serdexmethylphenidate, one of the active ingredients in AZSTARYS capsules, depicted with a benzene ring, ester, and piperidine ring along with HCl notation indicating its hydrochloride form.*

FDA Label Image

Figure 1 (Azstarys 03)

A line graph comparing mean dexmethylphenidate plasma concentration (ng/mL) over time (hours) between AZSTARYS 52.3/10.4 mg and Dexmethylphenidate HCl ER Capsule 40 mg. The x-axis represents time in hours up to 72 hours, and the y-axis shows plasma concentration up to 30 ng/mL, with two distinct curves corresponding to each drug.*

FDA Label Image

Figure 2 (Azstarys 04)

Line graph showing the LS Mean SKAMP-Combined Change from Baseline over time (hours) comparing AZSTARYS capsules to placebo. The graph plots a decrease for AZSTARYS starting near 0 hours, reaching a low around 2 hours, then gradually rising toward baseline by 12-13 hours. Placebo values remain near zero with minimal change throughout the time course.*

FDA Label Image

26 mg 100 Count Bottle Label (Azstarys 05)

AZSTARYS capsules containing serdexmethylphenidate and dexmethylphenidate, 26.1 mg / 5.2 mg strength, in a package of 100 capsules. The label includes dosage form as oral capsules and highlights storage instructions, dosage advisory, and pharmacist attention note. The product is distributed by Corium, Inc., with NDC 65038-286-99.*

FDA Label Image

39 mg 100 Count Bottle Label (Azstarys 06)

Label for AZSTARYS capsules containing serdexmethylphenidate 39.2 mg and dexmethylphenidate 7.8 mg per capsule. The label includes the brand name, active ingredients, strength, and a note instructing pharmacists to provide the medication guide. It states the product is prescription only and distributed by Corium, Inc.*

FDA Label Image

52 mg 100 Count Bottle Label (Azstarys 07)

Label for Azstarys capsules containing 52.3 mg Serdexmethylphenidate and 10.4 mg Dexmethylphenidate per capsule. The label includes storage instructions, dosage advisory to see package insert, manufacturer Corium, Inc., and a statement to dispense in a tight, light-resistant container away from children. Package size is 100 capsules, NDC 65038-561-99.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.